Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 19 (2), 119-23

Current Management for Epilepsy in Tuberous Sclerosis Complex

Affiliations
Review

Current Management for Epilepsy in Tuberous Sclerosis Complex

Paolo Curatolo et al. Curr Opin Neurol.

Abstract

Purpose of review: This article reviews the most significant advances in the field of epilepsy associated with tuberous sclerosis complex, with emphasis on new advances in the knowledge of the pathophysiological mechanisms of epileptogenicity, progress in identifying the epileptogenic zone, and the rationale for surgical management in individuals with intractable seizures.

Recent findings: Advances in our understanding of the mechanisms and genetics underlying infantile spasms and catastrophic epilepsy associated with tuberous sclerosis complex may facilitate more effective interventions. Early effective seizure control could significantly reduce the adverse developmental effects of chronic epilepsy in tuberous sclerosis. Vigabatrin is the first choice in the short-term treatment of infantile spasms. Some individuals, however, develop seizures that remain highly intractable. The factors that influence the intractability of epilepsy associated with tuberous sclerosis complex remain poorly understood. Multimodality neuroimaging has improved detection of epileptogenic foci, allowing an increased number of individuals to be evaluated for resective surgery. Epilepsy surgery is often associated with significant improvement of the neurologic outcome.

Summary: Epilepsy in tuberous sclerosis seems to arise from the interaction between multiple areas, all of which have increased excitability and reduced inhibition. Understanding the mechanisms of epileptogenesis might increase the availability of development of a more specific and efficacious treatment. New evidence suggests that it is possible to noninvasively identify children with tuberous sclerosis who are highly likely to become seizure free following surgical treatment.

Similar articles

  • Epilepsy Surgery for Tuberous Sclerosis
    P Romanelli et al. Pediatr Neurol 31 (4), 239-47. PMID 15464634. - Review
    Tuberous sclerosis complex is often associated with medically refractory epilepsy secondary to cortical tubers. Previous studies have identified an association between ea …
  • Management of Epilepsy in Tuberous Sclerosis Complex
    P Curatolo et al. Expert Rev Neurother 8 (3), 457-67. PMID 18345974.
    Tuberous sclerosis complex (TSC) is an inherited disorder resulting from mutations in one of two genes, TSC1 (Hamartin) and TSC2 (Tuberin). These two proteins form a cyto …
  • Tuberous Sclerosis and Epilepsy
    LD Petrova. Am J Electroneurodiagnostic Technol 51 (1), 5-15. PMID 21516926.
    Tuberous Sclerosis Complex (TSC) is an inherited disorder resulting from mutations in one of two tumor suppressor genes: TSC1 (hamartin) and TSC2 (tuberin). Hamartin and …
  • Long-term Neurological Outcome in Children With Early-Onset Epilepsy Associated With Tuberous Sclerosis
    R Cusmai et al. Epilepsy Behav 22 (4), 735-9. PMID 22142783.
    In tuberous sclerosis complex, early seizure onset is associated with high risk of intractable epilepsy and cognitive/behavioral impairment. We retrospectively evaluated …
  • Managing Epilepsy in Tuberous Sclerosis Complex
    EA Thiele. J Child Neurol 19 (9), 680-6. PMID 15563014. - Review
    Epilepsy is very common in tuberous sclerosis complex and occurs in 80 to 90% of affected individuals during their lifetime. Onset usually occurs during childhood, and up …
See all similar articles

Cited by 13 PubMed Central articles

See all "Cited by" articles
Feedback